with Dr. James Inkster, Dept. of Chemistry & Chemical Biology
Location: BSB 137
Abstract: Early disease diagnosis is essential for effective treatment. The Radiochemistry and Radiopharmaceuticals Research Group specializes in developing radiolabelled probes targeting molecular biomarkers expressed by disease and infection to detect pathology early. Radiolabelled molecular probes are detected throughout the course of disease by Positron Emission Tomography (PET) or Single Photon Emission Computed tomography (SPECT) for accurate staging leading to improved treatment.
This is a great opportunity to get acquainted with exciting research on campus and network with faculty.
